• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · March 25, 2021

COVID Innovations March 25th, 2021

Author: Dr. Linda Morrow – March 25th, 2021 Imagine a pandemic without having to shut down our lives. Imagine governments and industry working cooperatively to develop diagnostic and vaccine …

News · March 22, 2021

Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease

laboratory

Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and territory rights ACER-001 pre-NDA meeting with U.S. FDA scheduled in Q2 2021 GENEVA, SWITZERLAND and …

News · March 4, 2021

Access Vascular, Inc. Secures $20 Million in Series B Financing

laboratory

Bedford, MA – 03 March, 2021- Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. …

News · February 25, 2021

Kent’s deal with Net Health to expand Snapshot’s footprint

handheld-kent-imaging

By David Godkin, Staff WriterTORONTO – Think of it. More than 14,000 facilities boasting 98% of the largest hospital chains across the U.S., two-thirds of skilled nursing facilities and hospice …

News · February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in Vespina Lifesciences Inc.

laboratory

Luxembourg, February 1st, 2021 – TVM Life Science Innovation II SCSp today announced the Fund’s investment establishing Vespina Lifesciences Inc., a company based in Newark, Delaware. Vespina …

News · February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in Sarkana Pharma, Inc.

laboratory

Luxembourg, February 1st, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s investment establishing Sarkana Pharma, Inc., a company based in Wilmington, Delaware. Sarkana …

News · January 19, 2021

TVM Life Science Innovation II SCSp Announces Investment in ImmunoRx Pharma, Inc.

laboratory

Luxembourg, January 19th, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s investment establishing ImmunoRx Pharma, Inc., a company based in Wilmington, Delaware. ImmunoRx Pharma, …

News · January 14, 2021

Kent Imaging Inc. is accelerating its growth through a US$15M investment by TVM Life Science Innovation II SCSp

handheld-kent-imaging

CALGARY, AB, CANADA, January 13, 2021 /EINPresswire.com/ -- Kent Imaging, an innovator in the tissue imaging market, announced today its partnership with TVM Life Science Innovation II SCSp to …

News · January 7, 2021

Emovi and SIAwards: 2nd interview on KneeKG and knee pain

emovi kneekg

The interview was live just before the award to Lebron James! The interview also presents Dr Michael Suk, orthopedic surgeon and clinical expert Luis Zuniga, PT owner, talking about the KneeKG. Here …

News · November 13, 2020

Dentsply Sirona and Panthera Dental announce collaboration: fully digital workflow for custom-made sleep devices

panthera

(Charlotte/Quebec, November 12, 2020) Dentists now have the opportunity to use Primescan in a new area of application: Obstructive Sleep Apnea (OSA) and snoring, which affects up to 3.61 billion …

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 29
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm’s history

October 27, 2020

CENTOGENE Announces Leadership Transition

October 22, 2020

2022 TVM Capital Winter Conference

September 8, 2020

CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares

July 15, 2020

CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares

July 10, 2020

  • in

Copyright © 2021 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact